To mark International Clinical Trials Day, The Clatterbridge Cancer Centre is aiming to raise awareness of clinical trials and how one of the largest, networked cancer centres in the UK is helping to deliver clinical trials across the region.
The Clatterbridge Cancer Centre celebrated ten years as the host of the Merseyside and Cheshire Cancer Research Network last year, which has helped increase the number of local people being recruited to take part in international cancer research from four per cent to 23 per cent since 2002.
The Clatterbridge Cancer Centre works collaboratively with a number of research partners to provide access to over 120 international clinical trials which test new treatments for cancer aimed at ensuring patients experience the best available cancer care.
Clinical trials are a crucial part of investigating which treatments and medicines work best for patients. By taking part in research, patients can help improve cancer provision for future generations.
The Clatterbridge Cancer Centre is a research active organisation and has a history of referring patients from Merseyside and Cheshire onto work leading clinical trials. It has a broad range of clinical trials in every area of cancer.
The Clatterbridge Cancer Centre has developed excellent relationships with partner organisations including The National Institute for Health Research (NIHR), The University of Liverpool and the Liverpool Cancer Trials.
Professor Carlo Palmieri is consultant medical oncologist at The Clatterbridge Cancer Centre and Professor of Translational Oncology. His research specialism is in the treatment of breast cancer, through both clinical and translational research.